07 session he chaired entitled "ST Elevation Myocardial Infarction: The First 24 Hours." Dr. Smith: I'm Dr. Sidney Smith and with me is Dr. Elliott Antman, director of the Samuel A. Levine Cardiac ...

As recently as 40 years ago, biomarkers used for the diagnosis of acute myocardial infarction (MI) were nonspecific and assays were not highly reproducible from one laboratory to another.

Following injury, many organs are capable of rapid regeneration of necrotic tissue to regain normal function. In contrast, ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

An anterior myocardial infarction results from occlusion of the left anterior descending coronary artery. This can cause an ST elevation myocardial infarction or a non-ST segment elevation ...

Myocardial infarction or 'heart attack' is a type of acute coronary syndrome in which sudden blockage of a coronary artery, and subsequent myocardial ischaemia, results in damage to the ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.

A non-transmural myocardial infarction refers to a myocardial infarction that does not involve the full thickness of the myocardium. It was one believed that the development of Q waves indicated ...

The dual SGLT1/2 inhibitor yielded a 32% reduction in myocardial infarction risk and 34% reduction in stroke risk. It's first SGLT inhibitor to provide a significant reduction in both myocardial ...